Sanofi India Limited — Updates, 14-05-2025: Press Release

Sanofi India has announced a board meeting on May 14, 2025, to approve the financial results for the quarter and half-year. Q1 net sales grew 4%, with operating profits up 27% to ₹162 Cr, driven by strong demand for diabetes drug Soliqua® and better cost management. The ‘India for India’ strategy is enhancing market reach and operational efficiency, supporting innovation and portfolio expansion in the Indian market.